Aytu Biopharma (AYTU) Total Debt (2011 - 2026)
Aytu Biopharma (AYTU) posted quarterly Total Debt of $11.4 million for Q1 2026, little changed year-over-year from $11.4 million in Q1 2025, and down 40.2% quarter-over-quarter from $19.1 million in Q4 2025.
Aytu Biopharma (AYTU) Total Debt (2011 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Total Debt for 15 consecutive years, with $11.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt changed 0.12% year-over-year to $11.4 million; the TTM figure through Mar 2026 stood at $11.4 million (changed 0.12% YoY), while the FY2025 annual figure was $20.0 million, up 50.38% from the prior year.
- Total Debt declined to $11.4 million in Q1 2026 per AYTU's latest filing, from $19.1 million in the prior quarter.
- Across five years, Total Debt topped out at $23.1 million in Q3 2022 and bottomed at $1.6 million in Q1 2024.
- Historically, Total Debt has averaged $14.6 million across 5 years, with a median of $14.7 million in 2023.
- Annual changes were most pronounced in 2022 — Total Debt soared 995.36% — and 2024, when it plunged 89.24%.
- Aytu Biopharma's Total Debt stood at $14.6 million in 2022, then gained by 9.44% to $16.0 million in 2023, then dropped by 26.02% to $11.8 million in 2024, then jumped by 61.09% to $19.1 million in 2025, then sank by 40.2% to $11.4 million in 2026.
- Business Quant data shows AYTU's Total Debt at $11.4 million in Q1 2026, $19.1 million in Q4 2025, and $12.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 760.00 Mn |
| 10 | Aytu Biopharma | 23.86 Mn | -2.85 Mn | 7.60 Mn | 19.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.41 Mn |
| Dec 31, 2025 | 19.07 Mn |
| Sep 30, 2025 | 12.30 Mn |
| Jun 30, 2025 | 19.96 Mn |
| Mar 31, 2025 | 11.39 Mn |
| Dec 31, 2024 | 11.84 Mn |
| Sep 30, 2024 | 14.70 Mn |
| Jun 30, 2024 | 13.27 Mn |
| Mar 31, 2024 | 1.58 Mn |
| Dec 31, 2023 | 16.00 Mn |
| Sep 30, 2023 | 14.90 Mn |
| Jun 30, 2023 | 16.28 Mn |
| Mar 31, 2023 | 14.69 Mn |
| Dec 31, 2022 | 14.62 Mn |
| Sep 30, 2022 | 23.09 Mn |
| Jun 30, 2022 | 18.09 Mn |
| Mar 31, 2022 | 14.27 Mn |
| Dec 31, 2021 | 1.34 Mn |
| Sep 30, 2021 | 4.67 Mn |
| Jun 30, 2021 | 16.85 Mn |